Search results for: 'coupl next'

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

28 Sep 2015  |  Asia Pacific  |  Market Research

End-User Perspectives on the SEA RIS/ PACS Market

Next-generation Imaging IT Needs Will Focus on Interoperability

Infographics

×

Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

14 Feb 2020  |  Asia Pacific  |  Market Research

Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

Infographics

×

This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

Asia-Pacific represents the fastest growing region for healthcare information technology (healthcare IT) solutions across the world. Rapidly changing demographic factors coupled with fast-moving government policies and legislations are allowing advanced IT tools to penetrate the market. These tools have the potential to change existing healthcare p...

The Chinese wound care market is in the growth stage. Growing ageing population and rise in the incidence of lifestyle diseases, coupled with the increase in risk of chronic wounds and in affordability of better quality of wound care products provide the impetus for the Chinese wound care market. Universal coverage of public health insurance scheme...

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

Indonesia has gathered much attention after implementation of the National Healthcare Scheme or JKN. Due to the heavy demand of healthcare services and supplies, the market is expected to be an attraction for the next 2-3 years. The report evaluates the current scenario and shares the actual market conditions, hurdles and drivers for existing and n...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

12 Jul 2016  |  Asia Pacific  |  Market Research

Analysis of the APAC Health Information Exchange Market

 

Infographics

×

This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...